Article Details
Retrieved on: 2022-11-09 07:40:29
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
According to the data and analytics company, the current treatment options for aHUS in Japan are sparse with Alexion's Soliris (eculizumab) and ...
Article found on: www.financialexpress.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here